INSIGHTS ON CLINICAL TRIAL PARTNERING

• Should Sponsors Provide Source Document Templates?

  Here, we debate sponsor-provided source document templates, weighing regulatory guidance, compliance risks, and operational impacts for smarter clinical trial documentation decisions.

• Developing Community-Based And Trial-Naïve Sites: The Real ROI

  Trial-naïve sites, when supported with infrastructure, training, and network integration, represent a critical yet underused opportunity to expand patient access and accelerate recruitment.

• Innovative Approaches In Oncology Clinical Trials

  By embracing innovative trial models and strategic collaborations, oncology CROs play a pivotal role in bringing novel cancer therapies to market efficiently and effectively.

• Challenges That Derail Bladder Cancer Trials And How To Anticipate Them Earlier

  From the rapid evolution of standard-of-care benchmarks to the logistical strain of procedure-heavy urology workflows, the path to a successful endpoint is filled with operational friction.

• Why Should Site Agility Be Your Next Competitive Advantage?

  1/26/2026

  Maximize your trial agility by replacing slow, linear start-ups with parallel workflows and rapid SLAs. Partnering with agile sites secures a commercial edge and predictable timelines.

• cGMP Compliant Pharmacy

  5/1/2026

  See how experienced compounding support helps ensure study drugs are prepared accurately and consistently across administration routes, meeting cGMP requirements while supporting clinical protocols.

• Flexible Packaging, Labeling And Distribution For Diverse Drug Types

  3/24/2026

  Learn how demand-led and hybrid clinical supply models reduce waste, accelerate timelines, and improve flexibility for global trials through regional hubs and patient-specific packaging strategies.

• Tailored Approach Supports Bladder Cancer Breakthrough

  3/5/2026

  Discover how a flexible operational strategy and expert site management help bladder cancer programs overcome complex logistical hurdles and achieve critical regulatory milestones.

• Reducing Supply Risk in Cell & Gene Therapy Trials

  7/31/2026

  In cell and gene therapy trials, success depends on coordination. Learn how visibility, workflow control, and alignment help reduce risk and protect patient-specific treatments.